chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This study case was received from the investigator in a trial on 26 June 2013. A 28 year-old male subject whose past medical history included chest pain, shortness of breath and eczema was found to have other chest pain on the same day after the subject had received the following vaccines on 26 January 2011: an injection of ACAM2000 (lot number, route and site of administration not reported), Anthrax 1 (manufacturer, lot number, route and site of administration not reported) and Td, Adult absorbed vaccine (manufacturer, lot number, route and site of administration not reported). The Troponin I result, ECG and Echocardiogram were not available. Lumbar puncture (spinal tap) and MRI of the brain, spinal cord and heart were not performed. Treatments were not reported. The subject's outcome was not reported. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Documents held by sender: none.
This spontaneous report as received from a nurse refers to approximately 121 patients of unknown age and gender, who on an unknown date were vaccinated with a doses of PNEUMOVAX 23 (lot # L013428, expiration date 03-FEB-2017) stored in an incorrect temperature. No adverse effects reported. Additional information is not expected, due to lack of consent to contact with the reporter.
This spontaneous report as received from a medical assistant refers to unspecified number of patients of unknown age and gender. On an unknown date unspecified number of patients were vaccinated with (Oka/Merck) VARIVAX (dose, route and lot # not reported) that had been improperly stored. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Moderate muscle pain in neck, shoulders and back - day 3.   Minor pain at injection site and headache - day 1 & 2.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 01/09/21Lot# 2nd dose02/06/21 ,lot# Diagnosed covid positive:08/07/21 Symptom onset:08/03/21 Exposure: Symptoms:Runny nose, loss of smell
Not an adverse reaction but did not know where else to report ''My'' signs from having COVID-19 since February 24th (shortness of breath, fog brain, chest tightness , memory recall issues) got 50% better; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 23Apr2021 at 18:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, hypoparathyroidism, anxiety, depression, seasonal allergies, known allergies to band aid glue and COVID-19 (Prior to the vaccination, the patient was diagnosed with COVID-19). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medication. On 24Apr2021 at 08:00, the patient reported that it was not an adverse reaction but did not know where else to report, her signs from COVID 19 since 24Feb (shortness of breath, fog brain, chest tightness, memory recall issues) got 50 percent better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the event not an adverse reaction but did not know where else to report, signs from COVID 19 since 24Feb (shortness of breath, fog brain, chest tightness, memory recall issues) got 50% better was resolved on an unknown date in Apr2021.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Severe immune response x5 days Injection site has left a golfball size area where the muscle has ?disintegrated? it is so noticeable compared to the right side and very easily palpated. I am an NP and have had all the required vaccines and never has this happened. Coworkers and RN husband do not understand
Janssen COVID-19 Vaccine  Day 1: Fatigue within a couple of hours. Then within about seven hours I developed severe joint pains, chills, and headache. I took hot baths then iced my head.  Day 2: Very fatigued again, some headache Day 3: Fatigue persisted. Had to take off work. Headache.  Day 4: Nausea and lightheadedness. Can barely stand.  No fever throughout
The after the third vaccine when I woke up, I had a splitting headache, I ached all over and I had chills, real bad chills. That lasted 3 to 4 days. On the up-hand I did not have a fever. I had aches and pains with a splitting headache with the first two with no headache. The third was the worst all all 4. With the 4th I had aches and pains and a slight headache. The 4th one was the easiest of all. Sx resolved a little every day, but with the third one it was horrible every day.
In 24 hours after flu vaccine-stomach cramps diarrhea-lasting for 48 hours. Slowly improving-large red raised area on arm at injection site -arm hor to touch and painful.
2 inch rash at injection site with redness and burning; 2 inch rash at injection site with redness and burning; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (injection site redness), INJECTION SITE RASH (2 inch rash at injection site with redness and burning) and INJECTION SITE PAIN (2 inch rash at injection site with redness and burning) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (injection site redness). On 15-Feb-2021, the patient experienced INJECTION SITE RASH (2 inch rash at injection site with redness and burning) and INJECTION SITE PAIN (2 inch rash at injection site with redness and burning). At the time of the report, INJECTION SITE ERYTHEMA (injection site redness), INJECTION SITE RASH (2 inch rash at injection site with redness and burning) and INJECTION SITE PAIN (2 inch rash at injection site with redness and burning) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were reported.
Day after vaccine I had sore arm, swollen at the injection site, swollen ear lobes (lasted 24 hours), itching both arms, itching jaws, itching scalp,  2 days later still itching
There was no adverse reaction.  There was an error in administration, as the nurse gave a full 5 mL dose (from the multi dose vial) to the patient.  Follow-up with mother several days later indicated no adverse reaction except soreness at the injection site.
On January I had some blood tests done and my set rate was 111, white blood count 9.6, red blood count 4.01, hemoglobin 13.9, hemacrit 40.2 On 03/22/2021 after having the first dose my set rate 128, white blood count 12.1, red blood count 3.67 which is low, hemoglobin 12.9, and my hemacrit 36.1, platelets 153 On 05/06/2021 after having the second dose my set rate 122, white blood count 14.3, red blood count 3.63 which is low, hemoglobin 12.6, hemacrit 35.2, platelets 624. I still have stomach problems sometimes.
After DPT INJECTION upper arm was very sore... two weeks after severe bruise and still very sore... for three months knot could be felt under skin and still sore but since first month I have weakness in shoulder and still have very strong weakness cannot lift things high my shoulder will give out even if its just my handbag. The shoulder also feels achy and tender to pressure often for no reason. Also I cannot raise my arm from my side past about 8 inches without pain as it goes higher the pain is much more significant.
This spontaneous report as received from a Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # L010595 expiration date 12-NOV-2016 (dose and route of administration were not reported). There was no adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
Three days of severe pain and redness at injection site, fever, sweats, chills, dizzy, decreased appetite, serve headaches, high fever. Contacted doctor and pharmacist. They suggested I drinking a lot of fluid and take Tylenol or aspirin. Also, was very disappoints by the pharmacist that administered the shot to me. He said because of my thyroid I'm high risk for pneumonia however after talking to the physician he said that is totally false and I should of never gotten the shot. I know I should have been more educated on the shot however the pharmacist that admin it was wrong.  Three days later and still really sick
Acute onset of chest pain at 2:00 am on 4/8/21. Arrived at ER via ambulance at 4:30 am. Chest pain was extreme pressure, in chest radiating up through neck and lower left chest. Constant, worse when lying down or breathing deeply.  Evaluated in ER and subsequently admitted to the hospital. Diagnosed: Acute Idiopathic Pericarditis.
site of injection is itching; site of injection developed a red mark; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (site of injection is itching) and VACCINATION SITE ERYTHEMA (site of injection developed a red mark) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (site of injection is itching) and VACCINATION SITE ERYTHEMA (site of injection developed a red mark). At the time of the report, VACCINATION SITE PRURITUS (site of injection is itching) and VACCINATION SITE ERYTHEMA (site of injection developed a red mark) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
received the vaccine using an aspiration technique; This spontaneous case was reported by a consumer and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (received the vaccine using an aspiration technique) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (received the vaccine using an aspiration technique). At the time of the report, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (received the vaccine using an aspiration technique) outcome was unknown.            No Concomitant medications were provided by the reporter.  No Treatment medications were provided by the reporter.
Patient received the covid vaccine on 12/20/2020.   She tolerated without any problem.  On 12/28/2020 she found out her mom ( not living  in the same household ) tested positive for covid. She had face to face contact with her mother on 12/23/2020  On 12/30/2020 c/o new onset  sore throat and runny nose. Denies cough or fever.
6 MAY- softball size, itchy, textured skin patch on right arm 7 MAY- saw Flt Surgeon, pictures were taken, advised that reaction is "normal". 8 May- tired, scratchy throat 10-16 May- sore throat, very sore elbow/knee joints.  Feverish.  Metallic taste in mouth.  Sour stomach in the morning all week. 17-18 May- Headache.  Unable to concentrate. Back ache.  Sore joints.  Feverish. 19-21 May- Slightly better, still sore. 22-23 May- Constant sneezing and coughing, tired, sore joints, low-grade headache.  Diarrhea Sat night through Sun evening.  Patch has reduced to a small nodule, still itches. 24 May- Airway closes up as the day progresses, though itches up through ears.  Considered going to emergency room around 10pm b/c of extreme difficulty breathing.  Took Benadryl, breathing improved but not normal. 25 May- Went to Flt Surgeon, all symptoms still present.  Diagnosed symptoms as allergies and prescribed Claritin and Flo Nase.  Recommends hot compresses for nodule in arm.  Started medication, minimal relief.  Achy sinuses, knees, and neck.  Sore throat, generally tired. 26 May- General fatigue, feverish, unable to breathe deeply, coughing, sore knees and back. 27 May- Sore throat, knees, and lower legs. 28 May- Coughing continues, diarrhea in morning, sore back and knees, unable to breathe deeply. 29 May- Coughing, sore knees and back, congestion, fatigue, unable to breathe deeply. 30-31 May- No change. 1-2 Jun- Headache, fatigue, difficulty concentrating, nausea. 3-4 Jun- Very sore knees, other symptoms less obvious. 5 Jun 7 Jul- Most symptoms subside.  Joints, especially knees are still very sore. 8 Jul- Arm itches in spot where Anthrax Vaccine was administered.  Raised spot appears, approximately the size of a 1/2 dollar. 9 Jul- Arm itches, spot reduces to size of a quarter. 10 Jul- Arm itches, spot reduces to size of a dime.  Tried to see Reserve Flt Surgeon but was refused. 15 Jul- Spot recedes, nodule is still present. 21 Jul- Nodule is gone. 22 Jul - Present- I still have aching joints 3-4 times/week, especially in my knees.  I have been active in sports my entire life and have never had this type of pain, which started suddenly after Anthrax shot #6.
Chills and fever above 101 for the second half of the vaccine day and all of the following day. Aches and pain in arm, headache for three days.
This spontaneous report as received from a medical assistant in physicians office via field representative refers to a male patient (medical assistants son). The patient's drug allergies were unspecified and the pertinent medical history included some birth problems and feet turned in wrong direction (worse braces to correct). On an unknown date the patient was vaccinated with M-M-R II (dose/frequency: standard milliliter (ml) one dose; Therapy Route: Unspecified and lot # and expiry date were unspecified) a few months prior to being 18 months of age. Concomitant medications were unspecified. The patient developed mumps and measles after receiving the M-M-R II around 18 months of age. The patient also received M-M-R II at 20 years of age approximately in August 2014 (reported as now 20 years) and then developed mumps and measles. The patient sought medical attention and treatment provided was unspecified. The outcome of developed mumps and measles, developed mumps and measles was reported as recovered on an unspecified date. The causality of measles and mumps was not reported. No product quality complaint (PQC) was reported for M-M-R II. Additional information has been requested.
I didn't have any adverse events nor side effects. Am reporting this as I don't think the shot was administered correctly. I didn't feel the shot and I didn't have any muscle pain.
Pt recvd Engerix-B & 2 wks ago had elevated SGOT, pos ANA, abn liver function tests & alkaline phosphatase dec;
Vial diluted incorrectly. Patient received 42 mcg of Pfizer vaccine. No adverse reaction reported by patient.   On 1/4/2021 patient became COVID + after 2 COVID + contacts
Tiredness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FD0809) via an unspecified route of administration on 01Nov2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to trees flowering, apples and honey. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301558A) via an unspecified route of administration on 11Oct2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 01Nov2021, the patient experienced tiredness and headache. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness and headache was unknown at the time of the report.
No adverse effect reported; the 4 year old patient was inadvertently administered an adult dose of VAQTA; This spontaneous report was received from  a nurse prescriber referring to 4 year-old patient of unknown gender.       The patient's medical history, concurrent conditions and concomitant therapies were not provided.           The nurse reported that on 30-JUL-2019, the patient was inadvertently administered an adult dose of Hepatitis A Vaccine, Inactivated(VAQTA) 50/1.0 U/ml (lot # S010726, expiration date; 06-MAR-2020, dose, route and anatomical location were not reported) for prophylaxis. No adverse effect was reported. No further information was provided.
Ten days after vaccination in the evening my arm was pink and itchy. The next morning it was very red, swollen and itchy. It was an area below the injection covering most of my arm to the elbow on the outside of my arm. It was swollen, hot and uncomfortable. I was prescribed antibiotics and an antihistamine. The doctor thought it was a delayed allergic reaction. I stopped the antibiotics after three days and used an antihistamine and steroid cream. It took a bout a week for it to clear up. I got the second shot in the same arm and pre-medicated with some antihistamine. I only had some mild redness for a day.
Moderna COVID-19  Covid Arm - Approximatly 2 inch red circle at injection site on day 9-10.  Just appeared, note currently tender.
24 hr after flu shot had several incidents of postural hypotension - 24 hr later seems OK. Denies BP problems or medication. No other symptoms - totally resolved 72 hr later.
Severe headache,  bilateral ear pressure,  intense vomiting, chills, dizziness, fatigue, nausea
Woke up the evening of the 5th what felt like my heart stopped. I gasped for air. Had palpitations on and off that night. Next day I was ok until the evening again. Went for a drive, I started feeling light headed and tunnel vision my chest felt heavy and I continued to go into palpitations that would not stop. Couldn't get back into sinus rhythm. Went to ER. They admitted me because I would not stay in sinus rhythm with them as well
pt recvd vax & became febrile 48 hrs later & was hospitalized for several days for support, 02, ATB;
I felt immediate pain and soreness in left arm at injection site after injection. It is now day 3 after the injection and the area around my injection measuring about 5cmX6cm is palpably swollen, not erythematous, tender to touch, and itchy . I have put topical triamcinolone ointment that I use for eczema on the site to hopefully help with the itching and swelling. I have also taken Zyrtec.
This case was reported by a consumer (mother of the subject) via a pharmaceutical company and described the occurrence of brain lesion in a subject of unspecified age and gender who was vaccinated with ENGERIX B (GlaxoSmithKline). A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of ENGERIX B (unknown details). At an unspecified time after vaccination with ENGERIX B, the subject experienced brain lesion (described as "lesion on the frontal lobe"), change in behavior and psychiatric patient. Per the subject's mother, the subject "had behavioral changes after receiving ENGERIX B. The patient is in a psychiatric facility." No further adverse event information was provided. Contact information for follow up was not provided, therefore, the case has been closed. This case was assessed as medically serious by GSK. Relevant test results included a nuclear magnetic resonance imaging of brain (MRI). The results of the MRI "showed a lesion on the frontal lobe." At the time of reporting the outcome of the events were unspecified.
COVID Breakthrough Case  Pfizer Dose 1 2/16/21 (lot not listed in registry) Pfizer Dose 2 3/9/21 (lot not listed in registry) COVID Positive 10/9/21  10/9/21: Patient is a 81-year-old female with past medical history of morbid obesity, COPD, CKD 2-3, type 2 diabetes, hypertension, hypothyroidism, bilateral lymphedema and venous stasis, recent diagnosis of PE on anticoagulation, recent gastric ulcer was brought in from nursing home for hypotension.  History is obtained from patient's daughter, patient her medical records.  It appears that this morning patient was found to be hypotensive by staff and was brought to the ED.  It appears patient was on oxygen at nursing home and patient and family is not sure. Patient denies any chest pain, headache, dizziness, shortness of breath, nausea, vomiting, abdomen pain, dark stool or hematemesis.  Patient was recently admitted and was found to have a new PE was put on anticoagulation.  Patient had subsequent bleeding GI was consulted.  Patient was found to have the small gastric ulcer.   In the ED BP 104/29, HR 93, Temp 97.7, 100 % on 3 L NC. EKG showed AFib rate of 97. Creatinine 1.79, proBNP 1800, hemoglobin 6.6. fecal occult positive.  Patient received 1 unit of RBC in the ED.  GI consulted. BG dropped  10/16/21: Pt was admitted and underwent endoscopy evaluation with GI for acute blood loss anemia that resolved sp PRBC transfusion  There was initial concern for PE per VQ scan however CTPA negative for PE  Pt with elevated risk of bleeding including a history of gastric ulcer. Eliquis was on hold  She was treatd for mild COVID 19 infection. Remains on baseline O2 requirement  Wound care for chronic wounds by wound nurses  Home medications resumed as appropriate  Home hypoglycemics were on hold. Accucheks and insubq regimen was implemented  Patient discharged to SNF in stable conditions  Total time spent on d/c 45 min